CYTK icon

Cytokinetics

343 hedge funds and large institutions have $6.18B invested in Cytokinetics in 2024 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 120 increasing their positions, 131 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

less funds holding

Funds holding:

8% less repeat investments, than reductions

Existing positions increased: 120 | Existing positions reduced: 131

3.67% less ownership

Funds ownership: 114.94%111.27% (-3.7%)

14% less capital invested

Capital invested by funds: $7.15B → $6.18B (-$965M)

Holders
343
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
15
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$182M
Puts
$103M
Net Calls
Net Calls Change

Top Buyers

1 +$88M
2 +$51.6M
3 +$50M
4
UBS Group
UBS Group
Switzerland
+$41.8M
5
VPC
Vestal Point Capital
New York
+$40M

Top Sellers

1 -$217M
2 -$92.8M
3 -$61.1M
4
AC
Armistice Capital
New York
-$27.5M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$25.4M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$728M
2
$561M
3
$508M
4
$506M
5
$371M
6
$290M
7
$134M
8
$128M
9
$123M
10
$118M
11
$111M
12
$103M
13
$101M
14
$89.9M
15
$76.1M
16
$75M
17
$74.5M
18
$69.2M
19
$64.5M
20
$62.8M
21
$61.7M
22
$60.2M
23
$58.9M
24
$56.7M
25
$56.5M